Keybanc maintains Linde at Overweight, raises price target to $545 from $542

Keybanc reaffirmed its Overweight rating for Linde and increased its price target to $545 from $542, suggesting an 8.3% upside from the last close. Recent analyst targets for Linde range from $549 to $577.

Original reporting
Published Oct 30, 2026, 12:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 12:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Keybanc maintains Linde at Overweight, raises price target to $545 from $542 — source image
Decision brief

The 30-second read

$LINBullishMed
01

Why it matters

Analyst price‑target adjustments can influence short‑term trading activity.

02

Market read

A modest analyst upgrade may generate limited buying pressure on Linde shares.

03

What to watch

Potential headwinds from energy costs and supply chain constraints.

Relevance 6/10Novelty 5/10Timing: today

Background

Keybanc maintains an Overweight rating on Linde and nudges its price target upward.

Company-level read

Ticker impact

$LINBullishHigh confidence
Context

Keybanc raised Linde's price target to $545 from $542, indicating a modest upgrade.

Expected impact

potential modest upside as investors price in the higher target

Evidence & confidence

The price‑target increase signals improved outlook, likely prompting short‑term buying interest.

Market effects

Industrial gases sector may see slight uplift from analyst optimism.

European industrial stocks could benefit from the upgrade.

Limited; primarily affects Linde and peers.

Counterpoint

The target raise is marginal; price may already reflect the outlook.

Key entities

  • Linde plc

    Global industrial gases producer.

  • Keybanc Capital Markets

    Investment bank providing research coverage.

Related articles

$LINMedAI 8/10

Linde PLC (LIN) (Q3 2026) Earnings Call Highlights: Record Sales, Profit and EPS

Linde PLC (LIN) reported Q3 2026 record sales, profit, and EPS, but faced challenges in non-gas segments like Lincare, which reduced EPS growth by 2%. Q4 EPS guidance is $4.40-$4.50, a 3% sequential decline due to FX headwinds and seasonality. Europe and China markets remain weak. Management is evaluating strategic options for Lincare and expects no near-term recovery in Europe or China. Electronics growth is strong, supported by $2B in projects.

$LINMed

Linde plc Q3 2026 Earnings Call Summary

Linde plc reported Q3 2026 earnings, including a $425M restructuring charge. Lincare was moved to the Global Other segment. Chemicals and Energy grew 12%, Electronics 15%. Q4 EPS guidance is $4.40-$4.50. Management expects restructuring benefits by H2 2027 and Woodside ammonia project completion by H1 2027.

$LINMedAI 8/10

Linde Q3 Earnings Call Highlights

Linde (LIN) reported varied demand across regions and sectors in Q3, with electronics sales up 15% and chemicals/energy up 12%. U.S. packaged-gas growth remained in the low teens, while Europe saw flat market conditions. Linde's project backlog is near $8 billion, with the Woodside project expected to contribute financially in 2024. The company forecasted Q4 EPS of $4.40-$4.50, with full-year EPS at $17.82-$17.92.

$LINHighAI 8/10

Linde delivers a good quarter and puts in a fix for an overhang on the stock

Linde reported record Q3 revenue of $9.4B, up 9.2%, and adjusted EPS of $4.59, beating estimates. Shares fell 1% despite strong results due to light Q4 guidance. CEO addressed Lincare restructuring, taking a $425M charge. Sales grew in electronics, chemicals, and energy, with space propellant demand noted. Full-year EPS outlook raised to $17.87, in line with consensus. Linde maintains a $550 price target.